Behavioral/systems/cognitive Increased Cognitive Functioning in Symptomatic Huntington's Disease as Revealed by Behavioral and Event- Related Potential Indices of Auditory Sensory Memory and Attention

Cognitive functions are thought to deteriorate globally in late stages of various neurodegenerative disorders. Here we describe that this general assumption is not justified and fails in Huntington's disease (HD). Presymptomatic gene mutation carriers (pHDs) and healthy controls performed worse compared with symptomatic HDs in an auditory signal detection task. During task performance, behavioral data and event-related potentials (ERPs) [i.e., MMN (mismatch negativity), P3a, and RON (reorienting negativity)] were recorded. Not only behavioral performance but also neurophysiological correlates of auditory sensory memory and attentional reorientation indicate enhanced performance occurring primal in late stages of a neurodegenerative disorder. Increased activity of the NMDA-receptor system, an assumed pathogenic mechanism in HD, might facilitate signal propagation at striatal level that enables more efficient task execution through a winner-take-all process. The results challenge the view that late stage neurodegeneration is necessarily related to a global decline in cognitive abilities in HD. In contrast, selectively enhanced cognitive functioning can emerge together with otherwise impaired cognitive functioning.

[1]  C. Schroeder,et al.  Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Folstein,et al.  Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. , 1995, American journal of human genetics.

[3]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[4]  R. Näätänen,et al.  The mismatch negativity (MMN) in basic research of central auditory processing: A review , 2007, Clinical Neurophysiology.

[5]  C. Escera,et al.  Role of Mismatch Negativity and Novelty-P3 in Involuntary Auditory Attention , 2007 .

[6]  E Donchin,et al.  A new method for off-line removal of ocular artifact. , 1983, Electroencephalography and clinical neurophysiology.

[7]  Michael Falkenstein,et al.  ERP—Correlates of response selection in a response conflict paradigm , 2008, Brain Research.

[8]  G Bernardi,et al.  Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.

[9]  M. Falkenstein,et al.  Auditory distraction in young and middle-aged adults: a behavioural and event-related potential study , 2005, Journal of Neural Transmission.

[10]  Guillén Fernández,et al.  Interaction between the Human Hippocampus and the Caudate Nucleus during Route Recognition , 2004, Neuron.

[11]  J. Bolam,et al.  Synaptic organisation of the basal ganglia , 2000, Journal of anatomy.

[12]  E. Schröger,et al.  Psychophysics beyond sensation : laws and invariants of human cognition , 2004 .

[13]  Risto Näätänen,et al.  Auditory Discrimination After Left-Hemisphere Stroke: A Mismatch Negativity Follow-Up Study , 2003, Stroke.

[14]  Charles J. Wilson,et al.  GABAergic microcircuits in the neostriatum , 2004, Trends in Neurosciences.

[15]  I. Winkler,et al.  The concept of auditory stimulus representation in cognitive neuroscience. , 1999, Psychological bulletin.

[16]  Erich Schröger,et al.  Auditory distraction: event-related potential and behavioral indices , 2000, Clinical Neurophysiology.

[17]  C. Becker,et al.  On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[18]  H. Sauer,et al.  Effect of ketamine on the neuromagnetic mismatch field in healthy humans. , 2001, Brain research. Cognitive brain research.

[19]  A. Kalueff Neurobiology of Memory and Anxiety: From Genes to Behavior , 2007, Neural plasticity.

[20]  E. Schröger,et al.  A comparison of auditory and visual distraction effects: behavioral and event-related indices. , 2001, Brain research. Cognitive brain research.

[21]  Erich Schröger,et al.  Processing of Abstract Rule Violations in Audition , 2007, PloS one.

[22]  E. Schröger,et al.  Attentional orienting and reorienting is indicated by human event‐related brain potentials , 1998, Neuroreport.

[23]  E. Pekkonen Mismatch Negativity in Aging and in Alzheimer’s and Parkinson’s Diseases , 2000, Audiology and Neurotology.

[24]  Michael Falkenstein,et al.  Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis. , 2008, Journal of neurophysiology.

[25]  J. Brotchie,et al.  NMDA receptors in the basal ganglia , 2000, Journal of anatomy.

[26]  R. Näätänen,et al.  Early selective-attention effect on evoked potential reinterpreted. , 1978, Acta psychologica.

[27]  Carlos Cepeda,et al.  The corticostriatal pathway in Huntington's disease , 2007, Progress in Neurobiology.

[28]  Franz X Vollenweider,et al.  Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist in healthy volunteers , 2002, Biological Psychiatry.

[29]  M. Tervaniemi,et al.  The mismatch negativity in cognitive and clinical neuroscience: Theoretical and methodological considerations , 2007, Biological Psychology.

[30]  D. Plenz When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function , 2003, Trends in Neurosciences.

[31]  E. Miller,et al.  The prefontral cortex and cognitive control , 2000, Nature Reviews Neuroscience.

[32]  Jane S. Paulsen,et al.  Preclinical Huntington's disease: Compensatory brain responses during learning , 2006, Annals of neurology.

[33]  J. Epplen,et al.  NR2A and NR2B receptor gene variations modify age at onset in Huntington disease , 2005, Neurogenetics.

[34]  Juliana Yordanova,et al.  Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease? , 2007, Neuropsychologia.

[35]  Jane S. Paulsen,et al.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. , 2004, AJNR. American journal of neuroradiology.

[36]  B. Dubois,et al.  Riluzole in Huntington's disease: a 3‐year, randomized controlled study , 2007, Annals of neurology.

[37]  M. Beal,et al.  Experimental therapeutics in transgenic mouse models of Huntington's disease , 2004, Nature Reviews Neuroscience.

[38]  S. Pearson 'The neurochemistry of Huntington's Disease'. , 1992 .

[39]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.

[40]  E. Schröger Mismatch Negativity: A Microphone into Auditory Memory , 2007 .

[41]  Iiro P. Jääskeläinen,et al.  Inherited Auditory-Cortical Dysfunction in Twin Pairs Discordant for Schizophrenia , 2006, Biological Psychiatry.

[42]  Julie S. Snowden,et al.  Neuropsychological and neuropsychiatric aspects of Huntington's disease , 2002 .

[43]  Jeffery R Wickens,et al.  Inhibitory interactions between spiny projection neurons in the rat striatum. , 2002, Journal of neurophysiology.

[44]  Stephen Monsell,et al.  Task-Set Switching Deficits in Early-Stage Huntington's Disease: Implications for Basal Ganglia Function , 2003, Journal of Cognitive Neuroscience.

[45]  E. Miller,et al.  THE PREFRONTAL CORTEX AND COGNITIVE CONTROL , 2000 .